Home /  Market Reports

Categories

  • Market Reports

Pharmaceuticals

The pharmaceutical segment is engaged in researching, developing, manufacturing and marketing drugs & biologicals for human or veterinary use. This industry produces substances that are used in diagnosis, cure, treatment, and prevention of diseases e.g. pills, tablets, capsules, vials, ointments, vaccines, therapeutic proteins, antisera, tissues, etc.
 
Pharmaceutical products are segmented as:
  • Originator chemically-synthesized drugs
  • Generic drugs
  • Over-the-Counter (OTC) drugs
  • Pharmaceutical Substances: Active Pharmaceutical Ingredients (APIs) and Excipients
  • Biopharmaceuticals
  • Biosimilars or Follow-on Biologics
 
Globally, there is an increase in life expectancy against increasing incidence of chronic and infectious diseases. This has boosted the growth of pharmaceuticals market. The demand for innovative drugs has triggered the rise in R&D investments. 
 
Growing population, general economic growth, increase in health care spending levels is the main reasons for growth in these areas. On the other hand, pharmaceutical companies have many challenges, such as blockbuster drug patent expirations, competition from generic manufacturers and cost controls by national health policies.
 
The research reports and profiles listed in pharmaceutical segment comprise extensive range of market conditions, product trends, market data and analysis. Industry overviews, market share and growth, sales statistics and projections, and company profiles are also featured. Find the pharmaceutical market and industry analysis and databases.

PRODUCT TITLE
PUBLISH DATE
PRICE
Market Research Report
The report on the Global Medical Adhesives And Sealants Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

Medical adhesives and sealants are employed for critical medical applications. These adhesives and sealants offer high reliability and endurance at temperature changes. They exhibit properties such as biocompatibility, sterilization resistance, thermal stability and others.
 
Drivers
  • Rising geriatric population
  • Characteristics such as non-invasiveness, aesthetics and time efficiency
Restraints
  • Stringent regulations for medical grade products
  • Lack of proper reimbursement policies
 
Report includes a detailed analysis on value chain in order to provide a holistic view of the medical adhesives and sealants market. Value chain analysis comprises detailed evaluation of the roles of various players involved in the medical adhesives and sealants industry, from raw material suppliers to end-users.
 
Porter’s five forces model has been used to depict the impact of various factors such as:
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Degree of competition
  • Threat of substitutes
  • Threat of new entrants during the forecast period
 
Market attractiveness analysis has been included in order to analyze the application segments that are estimated to be lucrative during the forecast period on the basis of their market size and growth rate. Attractiveness of the market has been derived from market size, profit margin, growth rate, availability of raw materials, competition, and other factors such as social and legal constraints.
 
The medical adhesives and sealants market has further been segmented based on product such as synthetic medical adhesives and sealants (acrylic, cyanoacrylate, silicone, polyethylene glycol and other including polyisobutylene, polyurethane, epoxy); and natural medical adhesives and sealants (collagen, fibrin, albumin and other including lysine, cellulose, amino acid derivatives). The study provides forecast and estimates market for each product in terms of revenue and volume during the forecast period from 2019 to 2026. Each product has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
 
The medical adhesives and sealants market has been segmented based on applications such as dental, internal and external. The study provides forecast and estimates market for each application in terms of revenue and volume during the forecast period from 2019 to 2026. Each application has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
 
In terms of geography, the medical adhesives and sealants market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue and volume during the forecast period.
 
The report also offers a competitive landscape of the overall market with company profiles of players such as:
  • 3M Company
  • HB Fuller
  • Henkel AG
  • Baxter International
  • DENTSPLY Limited
  • CryoLife Inc.
  • Johnson and Johnson
  • Adhesive Research Inc.
  • Avery Dennison Corporation
  • Ashland, Inc.
  • Proctor & Gamble
  • King Pharmaceuticals
  • GlaxoSmithKline
  • Sybron Dental Specialties
  • Heraeus

A detailed description of the each company has been included and includes information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments provides a thorough idea about the competitive positioning of market players. The report also provides medical adhesives and sealants market's mergers/acquisitions, partnerships, collaborations, new product lunches, new product developments and other industry developments.
 
SEGMENTATIONS IN REPORT:
Medical Adhesives And Sealants By Product:
  • Synthetic Medical Adhesives And Sealants
    • Acrylic
    • Cyanoacrylate
    • Silicone
    • Polyethylene Glycol
    • Other (Including Polyisobutylene, Polyurethane, Epoxy)
  • Natural Medical Adhesives And Sealants
    • Collagen
    • Fibrin
    • Albumin
    • Other (Including Lysine, Cellulose, Amino Acid Derivatives)
 
Medical Adhesives And Sealants By Applications:
  • Dental
  • Internal
  • External
 
Medical Adhesives And Sealants By Geography:
  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East And Africa

The Global Medical Adhesives And Sealants Market has been exhibited in detail in the following some chapters -
Chapter 1 Medical Adhesives And Sealants Market Preface 
Chapter 2 Executive Summary
Chapter 3 Medical Adhesives And Sealants Industry Analysis
Chapter 4 Medical Adhesives And Sealants Market Value Chain Analysis
Chapter 5 Medical Adhesives And Sealants Market Analysis By Product
Chapter 6 Medical Adhesives And Sealants Market Analysis By Applications
Chapter 7 Medical Adhesives And Sealants Market Analysis By Geography
Chapter 8 Competitive Landscape Of Medical Adhesives And Sealants Companies
Chapter 9 Company Profiles Of Medical Adhesives And Sealants Industry

METHODOLOGY:
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.
October 2015
$3,950.00
Market Research Report
The report on the Global Gene Therapy Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2019 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

Gene therapy includes use of DNA as a pharmaceutical agent to treat diseases. It promises to be one of the most important frontiers in medicine and a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections). In the recent scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development. 
 
Gene therapy market is segmented by types, technology, applications, vectors and geography. On the basis of types the market is segmented into somatic gene therapy and germline gene therapy. On the basis of technology the market is further segmented by type of gene therapy, physical methods and chemical methods. On the basis of type of gene therapy the market is further segmented into ex vivo gene therapy and in vivo gene therapy. On the basis of physical methods the market is segmented into electroporation, microinjection, particle bombardment, ultrasound-mediated transfection, molecular vibration, laser irradiation, photochemical transfection. On the basis of chemical methods the market is further segmented into gene repair and replacement, gene editing by using short synthetic oligonucleotides, genome engineering by using TALENs, genome engineering by using CRISPR system, mRNA gene therapy, spliceosome mediated RNA trans-splicing. On the basis of application the market is segmented into oncology, infectious diseases, genetic disorders, cardiovascular disorders, diabetes mellitus, hypertension and neurological disorder. Based on geography the market is segmented into the North America, Europe, Asia and Rest of the World (RoW).
 
The growth is attributed to development in the gene silencing technology, increasing demand for gene therapy in immunodeficiency syndromes, growing popularity of DNA vaccines, and development in the nanotechnology.  However, stringent regulatory laws in U.S. and Europe for gene therapy, side effects of gene therapy, Occurrence of Multigene Disorders in Gene Therapy and technical limitations are hindering the growth of this market.
 
The key players in this market are:
  • AnGes MG, Inc
  • Ark Therapeutics
  • Ceregene, Inc
  • Cobra Biologics
  • GenVec, Inc
  • Genzyme Corporation
  • Vical, Inc
  • Oxford BioMedica
  • BioSante Pharmaceuticals
  • Shenzhen SiBiono GeneTech Co., Ltd
  • Transgene

SEGMENTATIONS IN REPORT:
By Type
  • Somatic Gene therapy
  • Germline Gene therapy
 
By Application
  • Genetic Disorders
  • Neurological Disorder
  • Oncology
  • Cardiovascular Disorders
  • Diabetes Mellitus
  • Infectious Diseases
  • Hypertension
 
By Technology
  • Ex vivo and in vivo gene therapy
    • Ex vivo gene therapy
    • In vivo gene therapy
  • Physical methods
    • Electroporation
    • Microinjection
    • Particle bombardment
    • Ultrasound-mediated transfection
    • Molecular vibration
    • laser irradiation
    • Photochemical transfection
  • Chemical methods
    • Gene repair and replacement
    • Gene editing by using short synthetic oligonucleotides
    • Genome engineering by using TALENs
    • Genome engineering by using CRISPR system
    • mRNA gene therapy
    • Spliceosome mediated RNA trans-splicing
            
By Type of Vectors
  • Viral vectors
  • Retroviral vectors
  • Nonviral vectors
  • Artificial viral vectors

By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (ROW)

The Global Gene Therapy Market has been exhibited in detail in the following chapters -
Chapter 1 Gene Therapy Market Preface 
Chapter 2 Executive Summary
Chapter 3 Gene Therapy Industry Analysis
Chapter 4 Gene Therapy Market Value Chain Analysis
Chapter 5 Gene Therapy Market Analysis  By Type
Chapter 6 Gene Therapy Market Analysis By Application
Chapter 7 Gene Therapy Market Analysis By Technology
Chapter 8 Gene Therapy Market Analysis By Type of Vectors
Chapter 9 Gene Therapy Market Analysis By Geography
Chapter 10 Competitive Landscape Of Gene Therapy Companies
Chapter 11 Company Profiles Of Gene Therapy Industry
October 2015
$3,950.00
Market Research Report
The report on the Global Hypodermic Needles And Syringes Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

A hypodermic needle is simply a hollow needle connected to a tube with a syringe to inject pharmaceutical drugs directly into the body or extract fluids from it. The market is expected  to grow at 7% annual growth rate for the foreseeable future.
 
For the purpose of this report the hypodermic needles market is segmented by type of product, such as disposable syringes, reusable/safety syringes, pen injectors, needle free injectors, and safety syringes. The safety syringes segment is further segmented into retrofitted syringe, automatic retractable syringe, manually retractable syringe and prefilled syringe. Based on the end users, the hypodermic syringes market is segmented into physicians, nurses, paramedics, and patients.
 
The hypodermic syringe market is poised for expansive growth mainly because of the ease-of-use factor that these syringes offer to patients and healthcare professionals and due to government support to minimize dosing errors and safety errors associated with use of needles. However, increase in packaging, transport, and storage costs, bulky size and weight, safety issues are some of the factors which are likely to dampen the market growth during the forecast period of 2020 to 2026.
 
Growing need of accurate dosing, need of greater patient compliance, and a reduced likelihood of contamination, need to reduce the overall cost per dosage unit are some of the unmet needs in the market which offer greater growth opportunities to the existing players in the market.
 
Some of the major players in the global hypodermic syringes market are:
  • B Braun Medical Inc.
  • Becton Dickinson medical
  • Catalent
  • Cook Pharmica
  • Covidien
  • Genentech
  • mediline industry Inc.
  • Novo Nordisk
  • Smiths Medical
  • Terumo Medical Corporation

SEGMENTATIONS IN REPORT: 
Global Hypodermic Needle and Syringe Market, By Products :
  • Disposable Syringe                    
  • Reusable/Safety Syringe                     
  • Pen Injectors                   
  • Needle-Free Injectors                   
  • Safety Syringes
    • Retrofitted Syringes              
    • Automatically Retractable Syringes              
    • Manually Retractable Syringes              
    • Prefilled Syringes

Global Hypodermic needle and syringe Market, By End User:
  • Physicians
  • Nurses
  • Paramedics
  • Patients
  • Others

Global Hypodermic needle and syringe Market By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

The Global Hypodermic Needles And Syringes Market has been exhibited in detail in the following chapters -
Chapter 1 Hypodermic Needles And Syringes Market Preface 
Chapter 2 Executive Summary
Chapter 3 Hypodermic Needles And Syringes Industry Analysis
Chapter 4 Hypodermic Needles And Syringes Market Value Chain Analysis
Chapter 5 Hypodermic Needles And Syringes Market Analysis By Products
Chapter 6 Hypodermic Needles And Syringes Market Analysis By End User
Chapter 7 Hypodermic Needles And Syringes Market Analysis By Geography
Chapter 8 Competitive Landscape Of Hypodermic Needles And Syringes Companies
Chapter 9 Company Profiles Of Hypodermic Needles And Syringes Industry
October 2015
$3,950.00
Market Research Report
The report on the Global Recombinant Expression Systems Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

An expression system is a system specifically designed for the production of a gene product of choice. This is normally a protein although may also be RNA, such as tRNA or a ribozyme. An expression system consists of a gene, normally encoded by DNA, and the molecular machinery required to transcribe the DNA into mRNA and translate the mRNA into protein using the reagents provided. Expression systems are classified on the basis of functionality, solubility, yield, level of target gene expression, and post translational processing.
 
The recombinant expression systems market is expected to grow owing to increased research in pharmaceutical sector and growth in biologics market. The overall growth in proteomics market is also a major factor driving this market. Decreased R&D expenditure and high market consolidation will hamper the growth of this market. Developing countries are expected to be high opportunity regions for global recombinant expression systems market.
 
This report segments the global recombinant expression market based on expression systems, products, and end users. This market is segmented on the basis of expression systems into insect cell expression systems, mammalian cell expression systems, prokaryotic expression systems, yeast expression systems, and other expression systems. On the basis of products, global recombinant expression systems market is segments include competent cells, expression vectors, instruments, reagents, expression vectors, instruments, reagents, and services. Academic research institutes, contract research organizations (CRO), pharmaceutical and biotechnology companies, and other end users Hospitals, diagnostic laboratories, research institutes, and others are the end-user segmentation of the recombinant expression systems market. The geographic segments included in this report are North America, Europe, Asia and Rest of the World.
 
Some of the major players of recombinant expression systems market include:
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc.
  • Life Technologies Corporation
  • Merck Millipore
  • New England Biolabs, Inc.
  • Promega Corporation
  • Qiagen
  • Sigma-Aldrich Corporation
  • Takara Bio, Inc. 
  • Thermo Fischer Scientific Inc. 

SEGMENTATIONS IN REPORT:
Global Recombinant Expression Systems Market, By Expression Systems
  • Insect Cell Expression Systems
  • Mammalian Cell Expression Systems
  • Prokaryotic Expression Systems
  • Yeast Expression Systems
  • Other Expression Systems

Global Recombinant Expression Systems Market, By Products
  • Competent Cells
  • Expression Vectors
  • Instruments
  • Reagents
  • Expression Vectors
  • Instruments
  • Reagents
  • Services

Global Recombinant Expression Systems Market, By End User
  • Academic Research Institutes
  • Contract Research Organizations (CRO)
  • Pharmaceutical and biotechnology companies 
  • Other end users

By Geographic
  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)

The Global Recombinant Expression Systems Market has been exhibited in detail in the following chapters -
Chapter 1 Recombinant Expression Systems Market Preface 
Chapter 2 Executive Summary
Chapter 3 Recombinant Expression Systems Industry Analysis
Chapter 4 Recombinant Expression Systems Market Value Chain Analysis
Chapter 5 Recombinant Expression Systems Market Analysis By Expression Systems
Chapter 6 Recombinant Expression Systems Market Analysis By Products
Chapter 7 Recombinant Expression Systems Market Analysis By End User
Chapter 8 Recombinant Expression Systems Market Analysis By Geography
Chapter 9 Competitive Landscape Of Recombinant Expression Systems Companies
Chapter 10 Company Profiles Of Recombinant Expression Systems Industry
October 2015
$3,950.00
Market Research Report
The report on the Global RNA Interference Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

RNAi (Ribonucleic Acid Interference) is an RNA-dependent gene silencing process that occurs in live cells to keep a check on the active genes. The major classes of RNAi are micro RNA and small interfering RNA. It is a valuable research tool to selectively induce suppression of genes of interest. RNAi is said to replace the existing recombinant technology in the field of drug discovery and therapeutics.
 
RNA Interference (RNAi) market is segmented by products, applications, delivery modes, and end users. RNA Interference (RNAi) market by products is segmented into design, monitoring/optimizing, and libraries. Based on the libraries, the market is divided into humans, mice, and rats. On the basis of applications, the market is segmented into research and development, therapeutics, drug discovery and development, and agriculture. Based on delivery mode, this market is segmented into vector based, transfection reagents, and electroporation. On the basis of end users, the market is divided into pharmaceutical companies, agriculture based industries, and biotechnology companies. Based on geographies, the market is divided into North America, Europe, Asia, and Rest of World (RoW).
 
The major factors driving growth of this market are increase in RNA therapeutic development and requirement of lower therapeutic dosages. Inefficiency in RNA drug delivery system is the major restraining factor to this market. Agriculture is an emerging field to use RNAi technology for crop improvement.
 
Some of the key players in this market are:
  • Qiagen N. V.
  • Invitrogen Corporation
  • Ambion, Inc.
  • Tekmira Pharmaceuticals Corporation
  • Merck & Co., Inc.
 
SEGMENTATIONS IN THE REPORT:
By Products:
  • Design
  • Monitoring/optimizing
  • Libraries
  • Humans
  • Mice
  • Rats
 
By Applications:
  • Research and Development
  • Therapeutics
  • Drug discovery and Development
  • Agriculture
 
By Delivery Modes:
  • Vector Based
  • Transfection Reagents
  • Electroporation
 
By End Users:
  • Pharmaceutical Companies
  • Agriculture Based Industries
  • Biotechnology Companies

By Geography:
  • North America (NA) – US, Canada & Rest of North America
  • Europe (EU) – UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) – China, Japan, India & Rest of APAC
  • Latin America (LA) – Brazil & Rest of Latin America
  • Middle East & Africa (MEA) – Middle East and Africa

The Global RNA Interference Market has been exhibited in detail in the following chapters -
Chapter 1 RNA Interference Market Preface 
Chapter 2 Executive Summary
Chapter 3 RNA Interference Industry Analysis
Chapter 4 RNA Interference Market Value Chain Analysis
Chapter 5 RNA Interference Market Analysis  By Products
Chapter 6 RNA Interference Market Analysis By Applications
Chapter 7 RNA Interference Market Analysis By Delivery Modes
Chapter 8 RNA Interference Market Analysis By End Users
Chapter 9 RNA Interference Market Analysis By Geography
Chapter 10 Competitive Landscape Of RNA Interference Companies
Chapter 11 Company Profiles Of RNA Interference Industry
October 2015
$3,950.00
Market Research Report
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin cancers. The major cause of skin cancer is exposure to ultraviolet (UV) rays from the sun. There are three major types of skin cancers as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. The first two skin cancers are grouped together as non-melanoma skin cancers. Other unusual types of skin cancer include Merkel cell tumors and dermatofibrosarcoma protruberans.
 
The increasing incidences of melanoma and non-melanoma skin cancer, technological advancements, availability of number of diagnostic products are some of the major drivers of skin cancer diagnostics market. However, requirement of large capital investment and limited patient base are the restraining factors of the global skin cancer diagnostics market. Furthermore, lack of competition for these products in high potential market creates an opportunity for this market.
 
The market is segmented into by type of cancer, by products, and by geography. The global skin cancer diagnostics market by type of cancer is segmented into basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. By products, the market is segmented into dermatoscopes, microscopes, imaging techniques, and optical coherence tomography scanners. The global skin cancer diagnostics market be geography is segmented as North America, Europe, Asia, and Rest of World (RoW).
 
Some of the major players of global skin cancer diagnostics market include:
  • Alma Lasers Ltd
  • Agilent Technologies Inc
  • Biolitec Ag
  • Bruker Corp
  • Ellipse A/S
  • Ge Healthcare
  • Leica Microsystems
  • Michelson Diagnostics Ltd
  • Syneron Medical Ltd
  • Toshiba Medical Systems

SEGMENTATIONS IN THE REPORT:
Global Skin Cancer Diagnostics Market, by Type
  • Basal cell carcinoma
  • Squamous cell carcinoma
  • Malignant melanoma

Global Skin Cancer Diagnostics Market, by Products
  • Dermatoscopes
  • Microscopes
  • Imaging Techniques
  • Optical Coherence Tomography Scanners

Geographic Analysis
  • North America
  • Europe
  • Asia
  • Rest of the World (RoW) 

The Global Skin Cancer Diagnostics Market has been exhibited in detail in the following chapters -
Chapter 1 Skin Cancer Diagnostics Market Preface 
Chapter 2 Executive Summary
Chapter 3 Skin Cancer Diagnostics Industry Analysis
Chapter 4 Skin Cancer Diagnostics Market Value Chain Analysis
Chapter 5 Skin Cancer Diagnostics Market Analysis By Type
Chapter 6 Skin Cancer Diagnostics Market Analysis By Products
Chapter 7 Skin Cancer Diagnostics Market Analysis By Geography
Chapter 8 Competitive Landscape Of Skin Cancer Diagnostics Companies
Chapter 9 Company Profiles Of Skin Cancer Diagnostics Industry
October 2015
$3,950.00
Market Research Report
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.
 
A number of factors such as increasing bone related disorders, increasing use of nanograft products by physicians, technological advancements, shortage of organs available for donation and high organ transplant rejection rate, advancement in nanotechnology research, increasing corporate and federal funding, and increasing contract manufacturing organizations are driving the growth of global regenerative medicine market. However, presence of alternative technologies, and high cost of the treatment are restraining the growth of this market. Furthermore, the factors such as, emerging nations such as India, and China, and reimbursement policies for regenerative medicine can create opportunities for this market in coming years.  
 
On the basis of segments, regenerative medicine market is divided into; stem cell therapy, gene therapy, phases of clinical trials, tissue engineering, and small molecules and biologics. 
 
On the basis of products the market is majorly divided into, cell therapy (CT) based products, tissue engineered (TE) products, bone and cartilage grafting and regenerative products, and electrical stimulators.
Based on the applications, the market is segmented into: bone and joints replacement, dental applications, neurologic applications, organ regeneration, applications in cardiovascular disorders, applications in urologic disorders and diabetes, and wound care.
 
Further, on the basis of geography the market is divided into, North America, Europe, Asia-Pacific, and Rest of the World (RoW).
 
Aastrom Biosciences, Inc., Advanced Cell Technology, Athersys, Inc., Amgen Inc., Bioheart, Inc., Cytori Therapeutics Inc., Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris Therapeutics, Inc., Japan Tissue Engineering Co.,  Ltd., ThermoGenesis Corp. are the key players of global regenerative medicine market.
 
Decision Databases is involved in providing research reports and company profiles in the global regenerative medicine market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The regenerative medicine market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our regenerative medicine profiles.
October 2015
$3,950.00
Market Research Report
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus on improving patient care outcomes, spending by healthcare organizations due to regulatory and industry mandates, and increasing demand of automation for cost reduction are driving the growth of high acuity care information systems market. However, decrease in investments, uncertain economic environment, and uncertainty among hospital’s approach towards enterprise or niche vendors are restraining the growth of this market. Increasing automation of various high acuity functions to improve facility capacity provide numerous opportunities for the market players.
 
In this report, the global high acuity care information systems market is broadly classified on the basis of products. The product segment is categorized into emergency department information systems, intensive care information systems, perinatal information systems, surgical information systems, and others. The surgical information system is further classified into peri-operative information systems and anesthesia information systems.
 
Geographically the market is divided into four regions, namely North America, Europe, Asia, and Rest of the World (RoW).
 
The report has profiled the leading players of this market along with the developments done by the companies over the past three years and strategic activities adopted by them to sustain and strengthen their position in the global high acuity care information systems market.

some of the key companies engaged in this market are
  • Affiliated Computer Services Inc. (U.S.)
  • Cerner Corporation (U.S.)
  • CompuGroup Medical Inc. (U.S.)
  • Computer Sciences Corporation (U.S.)
  • Epic Systems Corporation (U.S.)
  • General Electric Company (U.S.)
  • iMDsoft (U.S.)
  • Koninklijke Philips N.V (Netherlands)
  • OptumInsight, Inc. (U.S.)
  • Siemens Healthcare (Germany) 

SEGMENTATIONS IN REPORT: 
High Acuity Care Information Systems BY Products:
  • Emergency Department Information Systems
  • Intensive Care Information Systems
  • Perinatal Information Systems
  • Surgical Information Systems
  • Peri-Operative Information Systems
  • Anesthesia Information Systems
  • Others

High Acuity Care Information Systems Market By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

The Global High Acuity Care Information Systems Market has been exhibited in detail in the following chapters -
Chapter 1 High Acuity Care Information Systems Market Preface 
Chapter 2 Executive Summary
Chapter 3 High Acuity Care Information Systems Industry Analysis
Chapter 4 High Acuity Care Information Systems Market Value Chain Analysis
Chapter 5 High Acuity Care Information Systems Market Analysis By Products
Chapter 6 High Acuity Care Information Systems Market Analysis By Geography
Chapter 7 Competitive Landscape Of High Acuity Care Information Systems Companies
Chapter 8 Company Profiles Of High Acuity Care Information Systems Industry

METHODOLOGY:
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.
October 2015
$3,950.00
Market Research Report
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
 
In this report, the global molecular biology kits and reagents market is broadly classified on the basis of products, applications, and end users. The product segment is categorized into nucleic acid labeling kits, nucleic acid isolation and purification kits, PCR kits, siRNA Kits, cloning kits, cDNA synthesis kits, ribonuclease protection kits, and DNA sequencing kits. Based on applications, this market is further divided into molecular biology, biochemistry, microbiology, cell biology, and genetics. The end user segment of this market is categorized into pharmaceutical and biotechnology companies, hospitals and government research organizations, clinical research organizations, and academic institutes.
 
The report also covers the complete competitive landscape of the global Molecular Biology Kits And Reagents market with company profiles of key players such as:
  • Affymetrix, Inc.
  • Agilent Technologies
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Origene Technologies, Inc
  • Roche Applied Science.
  • Qiagen
  • Sigma-Aldrich Co. Llc
  • Thermo Fisher Scientific Corporation

SEGMENTATIONS IN REPORT:
Global Molecular Biology Kits And Reagents Market, By Products
  • Nucleic Acid Labeling Kits
    • Random Primer Labeling Kits
    • 5 Prime End Labeling Kits
  • Nucleic Acid Isolation And Purification Kits
  • Pcr Kits
  • Sirna Kits
    • Sirna Transfection Kits
    • Sirna Vector Kits
    • Sirna Labelling Kits
    • Sirna Transcription Kits
    • Other Sirna Kits
  • Cloning Kits
    • Pcr Cloning Kits
    • Blunt End Cloning Kits
    • Other Kits
  • Cdna Synthesis Kits
  • Ribonuclease Protection Kits
  • Dna Sequencing Kits
  • Other Kits
 
Global Molecular Biology Kits And Reagents Market , By Applications
  • Molecular Biology
  • Biochemistry
  • Microlbiology
  • Cell Biology
  • Genetics
  • Others
 
Global Molecular Biology Kits And Reagents Market, By Endusers
  • Pharmaceuticals And Biotechnology Companies
  • Hospitals And Government Research Organizations
  • Clinical Research Organizations
  • Academic Research
 
By Geographic
  • North America
  • Europe
  • Asia-Pacific (Apac)
  • Rest Of The World (Row)

The Global Molecular Biology Kits And Reagents Market has been exhibited in detail in the following chapters -
Chapter 1 Molecular Biology Kits And Reagents Market Preface 
Chapter 2 Executive Summary
Chapter 3 Molecular Biology Kits And Reagents Industry Analysis
Chapter 4 Molecular Biology Kits And Reagents Market Value Chain Analysis
Chapter 5 Molecular Biology Kits And Reagents Market Analysis By Product
Chapter 6 Molecular Biology Kits And Reagents Market Analysis By Applications
Chapter 7 Molecular Biology Kits And Reagents Market Analysis By Endusers
Chapter 8 Molecular Biology Kits And Reagents Market Analysis By Geography
Chapter 9 Competitive Landscape Of Molecular Biology Kits And Reagents Companies
Chapter 10 Company Profiles Of Molecular Biology Kits And Reagents Industry
October 2015
$3,950.00
Market Research Report
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method for treating various neurological injuries such as stroke, traumatic brain injury, spinal cord injury and other disorders. There are various types of systems which are used for neurological rehabilitations such as cortical simulation systems, neural reeducation systems, neurorobotic systems, rehabilitation gaming systems and software, and other systems.
 
The global neurorehabilitation systems market is expected to grow at a healthy CAGR during the forecast period of 2019 to 2026. Rising incidences of neurological disorders, growing need of automated monitoring and assessing activities of nervous systems, rising need to ensure improved treatment outputs are some of the major factors driving the growth of the neurorehabilitation systems market. In addition, multi-utility benefits of various neurological systems in the form of its application in treatment both neurological and orthopedic injuries, and other rehabilitative trainings would support the higher growth of this market during the forecast period. The report segments this market by lab type, procedure, end users and geography.
 

Some of the major players in the neurorehabilitation system market are:
  • AlterG Inc. (US)
  • Aretech LLC (US)
  • Bioness Inc. (US)
  • Bioxtreme Ltd. (Israel)
  • Hocoma AG (Switzerland)
  • Medtronic Inc. (US)
  • Mindmaze SA (Switzerland)
  • Reha Technology AG (Switzerland)
  • RehabLogic Inc. (US)
  • St. Jude Medical Inc. (US).

Scope of the Report:
This research report categorizes the global neurorehabilitation system market into the following segments:

SEGMENTATIONS IN REPORT: 
Neurorehabilitation System Market - Global, By System Type
  • Cortical Simulation Systems
  • Neural Reeducation Systems
  • Neurorobotic Systems
  • Rehabilitation Gaming System
  • Software
  • Other Systems
 
Neurorehabilitation System Market - Global, By Disorder Types
  • Stroke
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Parkinson's disease
  • Dystonia
  • Other Disorders
 
Neurorehabilitation System Market, By Geographies
  • North America
  • Europe
  • Asia
  • Row (Rest Of The World)

The Global Neurorehabilitation System Market has been exhibited in detail in the following chapters -
Chapter 1 Neurorehabilitation System Market Preface 
Chapter 2 Executive Summary
Chapter 3 Neurorehabilitation System Industry Analysis
Chapter 4 Neurorehabilitation System Market Value Chain Analysis
Chapter 5 Neurorehabilitation System Market Analysis By System Type
Chapter 6 Neurorehabilitation System Market Analysis By Disorder Types
Chapter 7 Neurorehabilitation System Market Analysis By Geography
Chapter 8 Competitive Landscape Of Neurorehabilitation System Companies
Chapter 9 Company Profiles Of Neurorehabilitation System Industry
October 2015
$3,950.00

© All Rights Reserved.